Dr. E. Puttemans
ActiveSummary
Dr. E. Puttemans has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €24,840 and a net result of €22,340. The computed 12-month bankruptcy probability is 0.8% (low).
Overview
- Equity
- €24,840
- Profit
- €22,340
Why 71raises riskFounded in 2024No main activity registeredlowers riskLiquidity: current ratio 4.73, cash €31,110Equity €24,840 (78.8% of total assets)Show the evidence
Checked score
About 8 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro): better than 81% on solvency, 84% on liquidity and 90% on profitability.
The bankruptcy probability was computed on 27-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Searched, nothing found (1)
- Annual accounts filedfinancial year 2025 · micro…
- IncorporationAppointment: PUTTEMANS Eline (director) ·…
Financials · financial year 2025, micro format
Turnover and EBIT margin not published: the micro format does not require them.
Peer companies
Historical observationOf the 39,278 companies that looked in July 2024 the way this one looks now, 1.8% went bankrupt within 24 months and 95.8% are still going.
- Micro
- 2 to 5 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 0.8% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 39,278 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2025 |
|---|---|
| Gross operating margin9900 | €28,551 |
| Operating profit (loss)9901 | €28,551 |
| Financial charges65/66B | €175 |
| Recurring financial charges65 | €175 |
| Profit (loss) for the period before taxes9903 | €28,376 |
| Income taxes67/77 | €6,036 |
| Profit (loss) for the period9904 | €22,340 |
| Profit (loss) for the period to be appropriated9905 | €22,340 |
| Line | 2025 | |
|---|---|---|
| Assets | ||
| Total assets20/58 | €31,507 | |
| Current assets29/58 | €31,507 | |
| Cash at bank and in hand54/58 | €31,110 | |
| Deferred charges and accrued income490/1 | €397 | |
| Equity and liabilities | ||
| Total equity and liabilities10/49 | €31,507 | |
| Equity10/15 | €24,840 | |
| Contributions10/11 | €2,500 | |
| Reserves13 | €22,340 | |
| Distributable reserves133 | €22,340 | |
| Amounts payable17/49 | €6,667 | |
| Amounts payable within one year42/48 | €6,667 | |
| Trade debts44 | €886 | |
| Suppliers440/4 | €886 | |
| Taxes, remuneration and social security45 | €3,936 | |
| Taxes450/3 | €3,936 | |
| Other amounts payable47/48 | €1,845 | |
| Line | 2025 |
|---|---|
| Profit (loss) for the period9904 | €22,340 |
| Operating cash flow (approximation) | €22,340 |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Filings with the National Bank (1)
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | micro format | 15-07-2026 | 2026-00293516 |
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Mandate history
- Board
| Name | Functions and periods |
|---|---|
| PUTTEMANS Eline |
|
Owners and capital
Capital and shareholders
- PUTTEMANS Eline 100 shares (100%) · €2,500 in cash
The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.
- 02-10-2024 Incorporation · €2,500 · 100 shares
Group and network
Connections & network
1 current directorThe network starts from this company’s directors. Other companies they run appear here as nodes.
History
Acts, filings and financial milestones
02-10
Gazette deed
IncorporationAppointment: PUTTEMANS Eline (director) · Founder · Founding capital6 facts ▸
- Incorporation, 30-09-2024
- Founder, PUTTEMANS Eline
- Founding capital, €2,500
- Registered office clause, “3000 Leuven, De Drie Kreeften 31”, 1104 (deed in Dutch)
- Board rule, 1
- Director appointment, PUTTEMANS Eline (director (not named in the articles))
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 28 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 establishment unit
1 parcel
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 24062A1103/00B000 | Flanders | 4,582 m² | 1 · 469 m² | - |
How the parcels are linked
Articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “De uitoefening van de geneeskunde, meer bepaald volgende disciplines: fysische geneeskunde en revalidatie door de arts-aandeelhouder, in…” (deed in Dutch)
14 activities (deed in Dutch)
- De uitoefening van de geneeskunde, meer bepaald volgende disciplines: fysische geneeskunde en revalidatie door de arts-aandeelhouder, in naam en voor rekening van de vennootschap, en rekening houdend met de bepalingen van de medische deontologie qua uitoefening van de geneeskunde.
- De geneeskunde wordt uitgeoefend door de arts onder specifieke aansprakelijkheid van de aandeelhouder en de bijkomende aansprakelijkheid van de vennootschap.
- De activiteit omvat impliciet de inning van de erelonen door en voor de vennootschap en de betaling aan de arts-aandeelhouder van een vergoeding in verhouding tot de prestatie die hij voor rekening van de vennootschap geleverd heeft.
- Het ter beschikking stellen van alle nodige middelen aan de arts, voor het beheren van een praktijk.
- Het inrichten van algemene diensten, en een medisch secretariaat in het bijzonder, die nuttig of nodig zijn voor de uitoefening van de voornoemde activiteiten.
- De aankoop, het huren, het leasen en het invoeren van alle medische apparatuur en begeleidende accommodaties voor voornoemde activiteiten.
- De mogelijkheden scheppen om de arts toe te laten zich verder te bekwamen in zijn discipline, dit teneinde een kwalitatief hoogstaande praktijkuitoefening mogelijk te maken.
- Het occasioneel verstrekken van onderwijs en geven van lezingen over voormelde medische onderwerpen, het schrijven en laten publiceren van medische artikels en boeken, het optreden als stagebegeleider.
- De vennootschap mag deelnemen aan alle andere vennootschappen die een gelijkaardig voorwerp nastreven of toetreden tot de associaties, met dezelfde of aanvullende specialiteiten, evenwel onder de voorwaarden bepaald in de medische deontologie.
- Overeenkomsten die artsen niet mogen afsluiten met andere artsen of derden, zullen echter ook door de vennootschap niet mogen afgesloten worden.
- De vennootschap kan zonder afbreuk te doen aan de medische deontologie ter zake, onder het normaal beheer als goede huisvader, een bestemming geven aan gereserveerde winsten van welke aard ook.
- Het verwerven en beheren van onroerende goederen of zakelijke rechten daarop, in België of in het buitenland.
- Het vormen en beheren van een roerend patrimonium bestaande uit lichamelijke of onlichamelijke roerende goederen.
- Het rationeel en doelmatig beheer van zowel haar roerend als haar onroerend vermogen. Binnen de perken van dit beheer zal de vennootschap alle handelingen kunnen stellen betreffende haar roerende en onroerende goederen, zoals onderhoud, bouwen, studie, renoveren, koop, verkoop, huur en verhuring, erfpacht en opstal, leningen met of zonder hypotheek, zonder dat deze opsomming beperkend weze.
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- Dr. E. Puttemans
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- One provision in the deed
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- 4 provisions in the deed
Capital, shares and profit
- Kind of sharesWhich classes of shares exist and what rights each class carries.
- “Op naam” (deed in Dutch)
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “Overdracht aandelen” (deed in Dutch)“Overgang aandelen overlijden” (deed in Dutch)“Gelijktijdig overlijden, punt A. 2) van artikel 11 toepassing” (deed in Dutch)6 more provisions on this in the deed
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Third Friday of June at 19:00
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- One provision in the deed
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Krachtens deze statuten indien geen andere vereffenaar zou zijn benoemd, bestuurder(s) in functie” (deed in Dutch)